Morgan Brown
Director of Finance/CFO chez CLENE INC.
Fortune : - $ au 31/03/2024
Profil
Morgan R.
Brown is currently the Chief Financial Officer at Clene Nanomedicine, Inc. and Clene, Inc. He previously held the position of CEO, Secretary & Head-Investor Relations at World Heart Corp.
from 2009 to 2012.
From 2000 to 2008, he worked as the Treasurer & Vice President-Finance at NPS Pharmaceuticals, Inc. In 2013, he briefly served as the Chief Financial Officer & Executive Vice President at Innovus Pharmaceuticals, Inc. Prior to that, he worked as a Senior Manager-Audit at KPMG LLP from 1993 to 2000.
He is also a member of The American Institute of Certified Public Accountants and the Utah Association of Certified Public Accountants.
Additionally, he was the Chief Financial Officer & Senior Vice President at Lifetree Clinical Research LC from 2008 to 2009.
Mr. Brown's education includes an MBA from the University of Utah and an undergraduate degree from Utah State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CLENE INC
-.--% | 13/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Morgan Brown
| Sociétés | Poste | Début |
|---|---|---|
| CLENE INC. | Director of Finance/CFO | 01/02/2022 |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Director of Finance/CFO | 01/02/2022 |
Anciens postes connus de Morgan Brown
| Sociétés | Poste | Fin |
|---|---|---|
| LIPOCINE INC. | Director of Finance/CFO | 31/01/2022 |
| INNOVUS PHARMACEUTICALS INC | Director of Finance/CFO | 01/09/2013 |
World Heart Corp.
 World Heart Corp. Miscellaneous Commercial ServicesCommercial Services World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT. | Chief Executive Officer | 01/08/2012 |
Lifetree Clinical Research LC
 Lifetree Clinical Research LC Miscellaneous Commercial ServicesCommercial Services Lifetree Clinical Research LC provides clinical research services. The company was founded by Alice A. Jackson in 2003 and is headquartered in Salt Lake City, UT. | Director of Finance/CFO | 01/08/2009 |
| NPS PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/01/2008 |
Formation de Morgan Brown
| University of Utah | Masters Business Admin |
| Utah State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LIPOCINE INC. | Health Technology |
| CLENE INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
World Heart Corp.
World Heart Corp. Miscellaneous Commercial ServicesCommercial Services World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT. | Commercial Services |
Innovus Pharmaceuticals, Inc.
 Innovus Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Innovus Pharmaceuticals, Inc. engages in the commercialization, licensing, and development of non-prescription medicine, and consumer care products for health and vitality, and respiratory diseases. Its products focuses in six main categories, including sexual health, pain management, general muscle health, respiratory, sleep, and diabetic care. The company was founded on January 15, 1959 and is headquartered in Englewood, CO. | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
| Utah Association of Certified Public Accountants | |
Lifetree Clinical Research LC
Lifetree Clinical Research LC Miscellaneous Commercial ServicesCommercial Services Lifetree Clinical Research LC provides clinical research services. The company was founded by Alice A. Jackson in 2003 and is headquartered in Salt Lake City, UT. | Commercial Services |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
